科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/03/31 | 4,420 | 4,430 | 4,330 | 4,335 | -110 | -2.5% | 190,000 |
| 2021/03/30 | 4,515 | 4,515 | 4,435 | 4,445 | -140 | -3.1% | 140,600 |
| 2021/03/29 | 4,585 | 4,620 | 4,545 | 4,585 | +5 | +0.1% | 188,200 |
| 2021/03/26 | 4,540 | 4,590 | 4,520 | 4,580 | +110 | +2.5% | 145,900 |
| 2021/03/25 | 4,480 | 4,510 | 4,460 | 4,470 | -15 | -0.3% | 128,700 |
| 2021/03/24 | 4,545 | 4,545 | 4,465 | 4,485 | -80 | -1.8% | 160,400 |
| 2021/03/23 | 4,655 | 4,670 | 4,565 | 4,565 | -50 | -1.1% | 162,900 |
| 2021/03/22 | 4,585 | 4,630 | 4,575 | 4,615 | +30 | +0.7% | 167,600 |
| 2021/03/19 | 4,555 | 4,610 | 4,540 | 4,585 | ±0 | ±0% | 230,000 |
| 2021/03/18 | 4,590 | 4,625 | 4,560 | 4,585 | +30 | +0.7% | 192,800 |
| 2021/03/17 | 4,475 | 4,555 | 4,450 | 4,555 | +120 | +2.7% | 143,900 |
| 2021/03/16 | 4,480 | 4,480 | 4,410 | 4,435 | -5 | -0.1% | 141,300 |
| 2021/03/15 | 4,305 | 4,440 | 4,305 | 4,440 | +145 | +3.4% | 213,600 |
| 2021/03/12 | 4,375 | 4,375 | 4,285 | 4,295 | -100 | -2.3% | 257,300 |
| 2021/03/11 | 4,470 | 4,485 | 4,375 | 4,395 | -60 | -1.3% | 186,700 |
| 2021/03/10 | 4,520 | 4,575 | 4,425 | 4,455 | +40 | +0.9% | 299,100 |
| 2021/03/09 | 4,300 | 4,420 | 4,290 | 4,415 | +160 | +3.8% | 224,000 |
| 2021/03/08 | 4,255 | 4,290 | 4,240 | 4,255 | +10 | +0.2% | 136,200 |
| 2021/03/05 | 4,250 | 4,275 | 4,220 | 4,245 | -10 | -0.2% | 250,300 |
| 2021/03/04 | 4,290 | 4,290 | 4,220 | 4,255 | -15 | -0.4% | 152,000 |
| 2021/03/03 | 4,285 | 4,295 | 4,235 | 4,270 | +20 | +0.5% | 139,300 |
| 2021/03/02 | 4,265 | 4,280 | 4,230 | 4,250 | ±0 | ±0% | 188,100 |
| 2021/03/01 | 4,260 | 4,265 | 4,205 | 4,250 | +15 | +0.4% | 240,400 |
| 2021/02/26 | 4,300 | 4,300 | 4,220 | 4,235 | +25 | +0.6% | 268,300 |
| 2021/02/25 | 4,240 | 4,245 | 4,170 | 4,210 | +20 | +0.5% | 138,500 |
| 2021/02/24 | 4,205 | 4,265 | 4,170 | 4,190 | +35 | +0.8% | 177,400 |
| 2021/02/22 | 4,150 | 4,200 | 4,135 | 4,155 | +10 | +0.2% | 153,600 |
| 2021/02/19 | 4,190 | 4,205 | 4,130 | 4,145 | -75 | -1.8% | 174,700 |
| 2021/02/18 | 4,225 | 4,235 | 4,190 | 4,220 | ±0 | ±0% | 146,600 |
| 2021/02/17 | 4,175 | 4,280 | 4,160 | 4,220 | +60 | +1.4% | 291,100 |
| 2021/02/16 | 4,115 | 4,170 | 4,115 | 4,160 | +50 | +1.2% | 175,700 |
| 2021/02/15 | 4,100 | 4,130 | 4,085 | 4,110 | +15 | +0.4% | 116,000 |
| 2021/02/12 | 4,060 | 4,095 | 4,040 | 4,095 | +75 | +1.9% | 199,100 |
| 2021/02/10 | 4,080 | 4,090 | 4,020 | 4,020 | -85 | -2.1% | 253,500 |
| 2021/02/09 | 4,105 | 4,135 | 4,075 | 4,105 | -25 | -0.6% | 201,200 |
| 2021/02/08 | 4,125 | 4,145 | 4,090 | 4,130 | -15 | -0.4% | 142,000 |
| 2021/02/05 | 4,125 | 4,150 | 4,110 | 4,145 | +20 | +0.5% | 108,900 |
| 2021/02/04 | 4,120 | 4,165 | 4,105 | 4,125 | +10 | +0.2% | 164,100 |
| 2021/02/03 | 4,050 | 4,135 | 4,045 | 4,115 | +40 | +1% | 147,200 |
| 2021/02/02 | 4,090 | 4,125 | 4,055 | 4,075 | -25 | -0.6% | 131,400 |
| 2021/02/01 | 4,120 | 4,140 | 4,085 | 4,100 | ±0 | ±0% | 138,000 |
| 2021/01/29 | 4,105 | 4,160 | 4,085 | 4,100 | -30 | -0.7% | 201,000 |
| 2021/01/28 | 4,050 | 4,140 | 4,050 | 4,130 | +15 | +0.4% | 168,700 |
| 2021/01/27 | 4,095 | 4,135 | 4,090 | 4,115 | +15 | +0.4% | 193,900 |
| 2021/01/26 | 4,080 | 4,115 | 4,075 | 4,100 | ±0 | ±0% | 111,500 |
| 2021/01/25 | 4,100 | 4,125 | 4,075 | 4,100 | +35 | +0.9% | 93,500 |
| 2021/01/22 | 4,040 | 4,085 | 4,035 | 4,065 | -25 | -0.6% | 123,300 |
| 2021/01/21 | 4,030 | 4,110 | 4,025 | 4,090 | +70 | +1.7% | 179,700 |
| 2021/01/20 | 4,030 | 4,040 | 3,990 | 4,020 | +5 | +0.1% | 262,600 |
| 2021/01/19 | 4,065 | 4,070 | 4,000 | 4,015 | -70 | -1.7% | 182,800 |
1001～
1050
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
